Risk factor
Very high price volatility
Profitability factor
Very low or no dividends
About
Fortrea Holdings Inc., a contract research organization, primarily engages in the provision of biopharmaceutical product and medical device development services worldwide. It operates through two segments: Clinical Services and Enabling Services. The Clinical Services segment provides across the clinical pharmacology and clinical development spectrum. The Enabling Services segment provides patient access and clinical trial technology...
Company Valuation
Based on key historical and expected multiples, the stock is slightly undervalued relative to its peers. In particular, the stock is overpriced on P/E, of fair value on E
Target Price
The average target price of FTRE is 16 and suggests 9% downside potential. Usually, this means a SELL recommendation among investment firms, or a recommendation to decrea
Buy
Sell